Dr Reddy's Laboratories recalls 58,656 bottles of heartburn drug in US

13 Mar 2014 Evaluate

Dr Reddy's Laboratories has recalled 58,656 bottles of the heartburn drug lansoprazole in the United States due to a microbial contamination. It was classified as a ‘Class II’ recall which indicates a remote chance of severe adverse consequences or death due to the product flaw.

Dr. Reddy’s is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products - the company offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, bio-similars, differentiated formulations and NCEs.

Dr. Reddys Lab Share Price

1298.95 24.90 (1.95%)
20-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1777.45
Dr. Reddys Lab 1298.95
Cipla 1255.85
Zydus Lifesciences 890.60
Lupin 2322.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×